149 related articles for article (PubMed ID: 26702753)
1. Abrupt Development of Plasma Cell Leukemia in a Patient with Chronic Anemia under Follow-up.
Farzaneh MR; Moradi A; Ravanbod MR; Daghbashi M
Arch Iran Med; 2016 Jan; 19(1):75-7. PubMed ID: 26702753
[TBL] [Abstract][Full Text] [Related]
2. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
[TBL] [Abstract][Full Text] [Related]
3. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell leukemia: a retrospective study of 10 cases.
Agarwal AD; Brahmbhatt BS; Parikh BP; Shah MJ
Indian J Cancer; 2014; 51(1):18-9. PubMed ID: 24947090
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell leukemia with myelofibrosis.
Murayama T; Matsui T; Hayashi Y; Taniguchi T; Ito M; Natazuka T; Imoto S; Iwata N; Isobe T; Ito H
Ann Hematol; 1994 Sep; 69(3):151-2. PubMed ID: 8086511
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of multi-agent chemotherapy with rituximab for IgM plasma cell leukemia.
Oka S; Yokote T; Akioka T; Hara S; Yamano T; Tsuji M; Hanafusa T
Leuk Res; 2006 Dec; 30(12):1581-3. PubMed ID: 16540168
[TBL] [Abstract][Full Text] [Related]
7. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
10. Plasma cell leukemia masquerading as ALL-L3--a case report.
Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
[TBL] [Abstract][Full Text] [Related]
11. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
12. Long term complete remission in primary plasma cell leukemia.
Tsuyuoka R; Takahashi T; Sasaki Y; Nakamura K; Fukumoto M; Kurisu Y; Tsubakimori K; Shioi K; Nakao K
Intern Med; 1995 Apr; 34(4):251-4. PubMed ID: 7606092
[TBL] [Abstract][Full Text] [Related]
13. Flaming Plasma Cell Leukemia.
Ranjbaran R; Golafshan H
Turk J Haematol; 2018 May; 35(2):134. PubMed ID: 28120778
[No Abstract] [Full Text] [Related]
14. [Plasma cell leukemia. Study of 6 patients].
Las Heras G; Ribera JM; Abella E; Batlle M; Flores A; Millá F; Feliu E
Sangre (Barc); 1992 Aug; 37(4):255-8. PubMed ID: 1514138
[TBL] [Abstract][Full Text] [Related]
15. Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report.
Delhommeau F; Huguet S; Gachet J; van den Akker J; Lagrange M
Acta Cytol; 2010; 54(2):187-9. PubMed ID: 20391976
[TBL] [Abstract][Full Text] [Related]
16. Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia.
Gentry M; Pettenati M; Pang CS
Int J Clin Exp Pathol; 2013; 6(10):2224-9. PubMed ID: 24133602
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Gemmel C; Cremer FW; Weis M; Witzens M; Moldenhauer G; Koniczek KH; Imbach U; Ho AD; Moos M; Goldschmidt H
Ann Hematol; 2002 Feb; 81(2):119-23. PubMed ID: 11907796
[TBL] [Abstract][Full Text] [Related]
20. [Primary plasmacytic lambda chain leukemia: report of a case].
Sztejnhaus AR; Santos RA; de Almeida TV
AMB Rev Assoc Med Bras; 1989; 35(3):120-2. PubMed ID: 2517460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
